본문 바로가기
bar_progress

Text Size

Close

[Breaking] Central Pharmaceutical Affairs Council: "Conditional Approval Possible for Celltrion's Regkirona Phase 3 Trial"


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top